CNBX Pharmaceuticals Inc. (CNBX) › Net IncomeCNBX Pharmaceuticals Inc. (CNBX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2005: -$1.8K2006: -$20.0K2007: -$23.2K2008: -$27.5K2009: -$114.9K2010: -$115.0K2011: -$107.3K2012: -$1.7K2013: -$56.4K2014: -$270.0K2015: -$541.4K2017: -$1.93M2018: -$3.78M2019: $1.13M2020: -$7.47M2021: -$3.19M2022: -$3.72M2023: -$3.71M2024: -$695.2K2025: -$314.0K-$314.0K2005Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$314.0K+54.8%2024-$695.2K+81.3%2023-$3.71M+0.3%2022-$3.72M-16.6%2021-$3.19M+57.2%2020-$7.47M-759.1%2019$1.13M+130.0%2018-$3.78M-95.3%2017-$1.93M—2015-$541.4K-100.5%2014-$270.0K-378.7%2013-$56.4K-3314.1%2012-$1.7K+98.5%2011-$107.3K+6.7%2010-$115.0K-0.1%2009-$114.9K-318.5%2008-$27.5K-18.3%2007-$23.2K-15.9%2006-$20.0K-1012.3%2005-$1.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share